Committed to sharing our science

Committed to sharing our science

scientist testing potential medicines

315 results available

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Shefner, JM et al

May 30, 2023
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Shefner JM, et al

August 29, 2023
Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3

Journal of Cardiac Failure

Owens AT, et al

July 18, 2023
Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure

The American Journal of Cardiology

Harrington J, et al

September 2, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

Journal of Cardiac Failure

Docherty KF, et al

September 6, 2023